Cargando…
Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection
Pyoderma gangrenosum (PG) is a rare and chronic neutrophil inflammation belonging to the spectrum of autoinflammatory disorders. Immunosuppressive therapy is the cornerstone of successful treatment. However, due to the global COVID-19 pandemic, physicians struggle with therapeutic strategies during...
Autores principales: | May, Marcella Ricardis, Rübben, Albert, Lennertz, Andrea, Vanstreels, Luk, Leijs, Marike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875703/ https://www.ncbi.nlm.nih.gov/pubmed/35207660 http://dx.doi.org/10.3390/jpm12020173 |
Ejemplares similares
Ejemplares similares
-
Novel topical cyclosporine as adjuvant therapy for pyoderma gangrenosum: A case series
por: Shah, Radhika, et al.
Publicado: (2023) -
Modified dose of guselkumab for treatment of pyoderma gangrenosum
por: Reese, Ashley M., et al.
Publicado: (2022) -
Penile pyoderma gangrenosum
por: Philip, Mariam, et al.
Publicado: (2013) -
Pyoderma gangrenosum: An update
por: Bhat, Ramesh M.
Publicado: (2012) -
Genital pyoderma gangrenosum
por: Bhat, Ramesh M., et al.
Publicado: (2014)